Premium
Singapore- and Delhi-based private equity firm Quadria Capital has struck its debut bet from its new healthcare-focused fund by investing in a contract research and manufacturing firm, two people familiar with the development told VCCircle. Quadria has picked 20-25% stake in Akums Drugs & Pharmaceuticals Ltd for Rs 500 crore (approximately $70 ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
